LAVA Therapeutics NV's earnings of $0.16 exceeded expectations, while profits were also higher than anticipated.

According to LAVA Therapeutics NV (NASDAQ: LVTX) report, the fourth quarter earnings per share came in at -$0.140, which is $0.16 better than analysts' expectations of -$0.300. The reported earnings for this quarter were set at $4.99 million, while analyst expectations were at $2.5 million.

LAVA Therapeutics NV's stock closed at $1.30, reflecting a 31,310% increase over the past three months. However, it has seen a significant decline of 61.560% over the last 12 months. Over the past 90 days, LAVA Therapeutics NV recorded one positive earnings per share and one negative. Explore how LAVA Therapeutics NV's stock price reacted to past earnings reports. According to InvestingPro, the company's financial health score is "Very Good." Check out the latest earnings reports and all financial information about LAVA Therapeutics NV. Stay updated on all developments regarding balance sheets by visiting Investing.com Earnings Calendar.